Search research articles
Contact Us
Filters
Showing results (11-20 of 71) with videos related to
Page
of 8
Sort By:
Clinical Medicine Insights. Oncology
|
June 23, 2011
Clinical development of cabazitaxel for the treatment of castration-resistant prostate cancer
Che-Kai Tsao, Sonia Seng, William K Oh, et al.
Targeted Oncology
|
December 3, 2025
Can PARP Inhibitors Benefit Patients with Homologous Recombination Repair-Proficient Castration-Resistant Prostate Cancer? A Meta-analysis
Susu Zhou, Devashish Desai, Noriko Kishi, et al.
Current Opinion in Urology
|
April 5, 2012
Overcoming castration resistance in prostate cancer
Che-Kai Tsao, Alexander C Small, Matthew D Galsky, et al.
CA: a Cancer Journal for Clinicians
|
April 27, 2012
Clinical development of novel therapeutics for castration-resistant prostate cancer: historic challenges and recent successes
Matthew D Galsky, Alexander C Small, Che-kai Tsao, et al.
Expert Review of Anticancer Therapy
|
December 21, 2012
Emerging personalized approaches for the management of advanced urothelial carcinoma
Che-Kai Tsao, Benjamin A Gartrell, William K Oh, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
April 16, 2013
Metabolic and toxicological considerations of newly approved prostate cancer drugs
Che-Kai Tsao, Bobby Liaw, Tiffany Yee, et al.
Cancers
|
November 13, 2025
Overcoming Immune Evasion in the Prostate Tumor Microenvironment: Novel Targeted Strategies to Improve Treatment Outcomes
Jing Huang, Ademola Ojo, Serena Tsao, et al.
Clinical Genitourinary Cancer
|
April 7, 2024
Cardiovascular Toxicity Associated With Androgen Receptor Axis-Targeted Agents in Patients With Prostate Cancer: A Meta-analysis of Randomized Controlled Trials
Susu Zhou, Parissa Alerasool, Noriko Kishi, et al.
Current Treatment Options in Oncology
|
September 16, 2017
Management of Atypical Renal Cell Carcinomas
Bobby C Liaw, Reza Mehrazin, Charles Baker, et al.
BJU International
|
September 19, 2012
Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)
Che-Kai Tsao, Matthew D Galsky, Alexander C Small, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 71) with videos related to
Sort By:
Page
of 8
Clinical Medicine Insights. Oncology
|
June 23, 2011
Clinical development of cabazitaxel for the treatment of castration-resistant prostate cancer
Che-Kai Tsao, Sonia Seng, William K Oh, et al.
Targeted Oncology
|
December 3, 2025
Can PARP Inhibitors Benefit Patients with Homologous Recombination Repair-Proficient Castration-Resistant Prostate Cancer? A Meta-analysis
Susu Zhou, Devashish Desai, Noriko Kishi, et al.
Current Opinion in Urology
|
April 5, 2012
Overcoming castration resistance in prostate cancer
Che-Kai Tsao, Alexander C Small, Matthew D Galsky, et al.
CA: a Cancer Journal for Clinicians
|
April 27, 2012
Clinical development of novel therapeutics for castration-resistant prostate cancer: historic challenges and recent successes
Matthew D Galsky, Alexander C Small, Che-kai Tsao, et al.
Expert Review of Anticancer Therapy
|
December 21, 2012
Emerging personalized approaches for the management of advanced urothelial carcinoma
Che-Kai Tsao, Benjamin A Gartrell, William K Oh, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
April 16, 2013
Metabolic and toxicological considerations of newly approved prostate cancer drugs
Che-Kai Tsao, Bobby Liaw, Tiffany Yee, et al.
Cancers
|
November 13, 2025
Overcoming Immune Evasion in the Prostate Tumor Microenvironment: Novel Targeted Strategies to Improve Treatment Outcomes
Jing Huang, Ademola Ojo, Serena Tsao, et al.
Clinical Genitourinary Cancer
|
April 7, 2024
Cardiovascular Toxicity Associated With Androgen Receptor Axis-Targeted Agents in Patients With Prostate Cancer: A Meta-analysis of Randomized Controlled Trials
Susu Zhou, Parissa Alerasool, Noriko Kishi, et al.
Current Treatment Options in Oncology
|
September 16, 2017
Management of Atypical Renal Cell Carcinomas
Bobby C Liaw, Reza Mehrazin, Charles Baker, et al.
BJU International
|
September 19, 2012
Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)
Che-Kai Tsao, Matthew D Galsky, Alexander C Small, et al.
Page
of 8